Initial empirical therapy for HAP, VAP and HCAP in

patient with Late onset of disease or risk factor for

MDR pathogens and all disease severity
Initial Intravenous, Adult doses of antibiotics for
empiric therapy of HAP, VAP and HCAP in patient
with late-onset disease or risk factors for MDR
pathogens